Cantor Fitzgerald Downgrades Cubist Pharmaceuticals (CBST) to Sell; Doesn't See Deal for Optimer (OPTR)
Tweet Send to a Friend
Cantor Fitzgerald downgraded Cubist Pharmaceuticals (NASDAQ: CBST) from Hold to Sell but raised its price target from $38 to $40 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
